Farther Finance Advisors’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $144 | Hold |
166
| – | – | ﹤0.01% | 4251 |
|
2025
Q1 | $272 | Hold |
166
| – | – | ﹤0.01% | 3892 |
|
2024
Q4 | $349 | Hold |
166
| – | – | ﹤0.01% | 3518 |
|
2024
Q3 | $506 | Hold |
166
| – | – | ﹤0.01% | 3421 |
|
2024
Q2 | $458 | Hold |
166
| – | – | ﹤0.01% | 3301 |
|
2024
Q1 | $568 | Hold |
166
| – | – | ﹤0.01% | 2981 |
|
2023
Q4 | $208 | Hold |
166
| – | – | ﹤0.01% | 3217 |
|
2023
Q3 | $166 | Hold |
166
| – | – | ﹤0.01% | 2489 |
|
2023
Q2 | $121 | Hold |
166
| – | – | ﹤0.01% | 2417 |
|
2023
Q1 | $452 | Buy |
+166
| New | +$452 | ﹤0.01% | 2029 |
|